nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanoma
|
Hillner, B.E |
|
1998 |
34 |
S3 |
p. 18-21 4 p. |
artikel |
2 |
Future perspectives in specific immunotherapy of melanoma
|
Parmiani, G. |
|
1998 |
34 |
S3 |
p. 42-47 6 p. |
artikel |
3 |
Incidence, risk factors and prevention of melanoma
|
MacKie, R.M |
|
1998 |
34 |
S3 |
p. 3-6 4 p. |
artikel |
4 |
Introduction
|
Eggermont, A.M.M |
|
1998 |
34 |
S3 |
p. 1-2 2 p. |
artikel |
5 |
New prognostic factors in melanoma: mRNA tumour markers
|
Keilholz, U |
|
1998 |
34 |
S3 |
p. 37-41 5 p. |
artikel |
6 |
Role of lymphatic mapping and sentinel node biopsy in melanoma detection
|
Ross, M.I |
|
1998 |
34 |
S3 |
p. 7-11 5 p. |
artikel |
7 |
Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma
|
Eggermont, A.M.M. |
|
1998 |
34 |
S3 |
p. 22-26 5 p. |
artikel |
8 |
Systemic adjuvant treatment of high-risk melanoma: the role of interferon Alfa-2b and other immunotherapies
|
Kirkwood, J.M |
|
1998 |
34 |
S3 |
p. 12-17 6 p. |
artikel |
9 |
The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma
|
Rusthoven, J.J |
|
1998 |
34 |
S3 |
p. 31-36 6 p. |
artikel |
10 |
The treatment of metastatic uveal melanoma
|
Pyrhönen, S |
|
1998 |
34 |
S3 |
p. 27-30 4 p. |
artikel |